Search IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Nasdaq · CIK 1425205
Last close14.22
Daily change-0.01 (-0.07%)
10 Years gain+76.21%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
IOVA · STANDARD
SIC 2836 · Biological Products, (No Diagnostic Substances) · Fiscal year end 1231
Fundamental
55.3Momentum
100.0Acceleration
100.0Confidence
69.0Annual Revenue13
Quarterly Revenue47
Annual CFO17
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth25.0 / 25
Quality12.5 / 25
Capital Efficiency0.0 / 20
Balance Sheet15.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 22.6131 percentage points.
Operating leverageOperating margin improved by 193.1664 percentage points.
Warnings
Heavy share dilution · HIGHDiluted share count increased 39.4344%.
High SBC · MEDIUMStock based compensation is high relative to revenue or FCF.
Key Metrics
Revenue Growth TTM113.42%OK
Revenue CAGR 3Yn/aINSUFFICIENT_HISTORY
Gross Margin41.82%OK
Operating Margin-114.58%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-63.76%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y39.43%OK
SBC / Revenue16.72%OK
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $263.50M | $90.32M | -$403.36M | -$302.41M | -$336.24M | 34.28% | -153.08% | -127.61% | -80.85% | 357,345 |
| 2025 FY Dec 31, 2024 | $164.07M | $70.82M | -$395.28M | -$352.98M | -$364.05M | 43.17% | -240.92% | -221.88% | -90.33% | 289,877 |
| 2025 FY Dec 31, 2023 | $1.19M | $156,000.00 | -$460.56M | -$361.82M | -$384.11M | 13.12% | -38,734.99% | -32,305.3% | -218.83% | 235,131 |
| 2024 FY Dec 31, 2022 | n/a | n/a | -$398.88M | -$292.76M | -$313.18M | n/a | n/a | n/a | n/a | 159,259 |
| 2023 FY Dec 31, 2021 | n/a | n/a | -$342.70M | -$227.94M | -$265.52M | n/a | n/a | n/a | n/a | 153,406 |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $298.15M | sum latest 4 fiscal quarters Revenue | OK | 0001104659-26-091716, 0001104659-25-107470 |
| Revenue Growth TTM | 113.42% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001104659-26-091716, 0001104659-25-107470 |
| Revenue CAGR 3Y | n/a | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | 0001104659-26-018899 |
| Revenue CAGR 5Y | n/a | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | INSUFFICIENT_HISTORY | 0001104659-26-018899 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | 0001104659-26-018899 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001104659-26-091716, 0001104659-25-107470 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 41.82% | Gross Profit / Revenue | OK | 0001104659-26-091716, 0001104659-25-107470 |
| Operating Margin | -114.58% | Operating Income / Revenue | OK | 0001104659-26-091716, 0001104659-25-107470 |
| ROIC | -63.76% | NOPAT / Average Invested Capital | OK | 0001104659-26-091716, 0001104659-25-107470 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001104659-26-091716 |
| Current Ratio | 4.35x | Current Assets / Current Liabilities | OK | derived |
| SBC / Revenue | 16.72% | SBC / Revenue | OK | 0001104659-26-091716, 0001104659-25-107470 |
| Revenue per Diluted Share | $662.28 | Revenue / Diluted Shares | OK | 0001104659-26-091716, 0001104659-25-107470 |